GlaxoSmithKline vet departs for Vifor, the rumored target of a $7.1B CSL buyout December 10, 2021 Auto Bot News 0 GlaxoSmithKline vet departs for Vifor, the rumored target of a $7.1B CSL buyout fkansteiner Fri, 12/10/2021 – 09:31
